Expression of Functional Membrane‐Bound and Soluble Catechol‐O‐Methyltransferase in Escherichia coli and a Mammalian Cell Line

Abstract: Human catechol‐O‐methyltransferase (hCOMT) cDNA was used to express the recombinant hCOMT enzyme in sufficient quantities in prokaryotic as well as in eukaryotic cells to allow kinetic studies. When human membrane‐bound catechol‐O‐methyltransferase (MB‐COMT; amino acids 1‐271) and the soluble catechol‐O‐methyltransferase COMT (S‐COMT; Δ membrane anchor hCOMT; amino acids 27‐271), with the latter lacking the first 26 hydrophobic amino acids, were expressed in Escherichia coli, a relatively high‐level synthesis of catalytically active enzymes was obtained. Insertion of the human MB‐COMT‐coding sequence into an eukaryotic expression vector under transcriptional control of the cytomegalovirus (CMV) promoter and enhancer yielded large quantities of hCOMT in human kidney 293 cells. Subcellular fractionation of 293 cells transfected with pBC12/CMV‐hCOMT showed hCOMT to be located predominantly in the membrane fraction. The catechol‐O‐methyltransferase (COMT) activity was measured in cytosolic and membrane fractions at 37°C, giving values of 33 and 114 units/mg of protein, respectively (1 unit produces 1 nmol of guaiacol/h). Km values were 10 μM for MB‐COMT and 108 μM for S‐COMT, indicating that recombinant MB‐COMT exhibits a higher affinity for catechol as the substrate than the soluble form. RNA blot analysis of human hepatome cells (Hep G2), kidney, liver, and fetal brain revealed only one species of hCOMT mRNA of ∼ 1.4 kb. Its level in these various tissues was similar to those of COMT protein in each tissue. Using the polymerase chain reaction (PCR) with primers surrounding the putative membrane anchor region, we have clearly identified a single‐size PCR product generated from hCOMT mRNA of various human tissues. Hence, the two forms of the enzyme cannot be the products of an alternative splicing of transcripts. We suggest that S‐COMT is generated by proteolytic cleavage between the NH2‐terminal membrane anchor and the catalytic domain of the membrane‐bound form. Lack of the N‐terminal fragments reduces the catalytic activity of the enzyme.

[1]  L. Wetterberg,et al.  Catechol‐O‐methyltransferase activity in erythrocytes in Down's syndrome , 1973, Clinical genetics.

[2]  D. Jeffery,et al.  Characterization of Membrane‐Bound and Soluble Catechol‐O‐Methyltransferase from Human Frontal Cortex , 1984, Journal of neurochemistry.

[3]  S. Kety,et al.  Amines and Schizophrenia , 1967 .

[4]  R. Pinder,et al.  3‐Hydroxy‐4‐methoxyphenethylamine: the endogenous toxin of parkinsonism? , 1972, The Journal of pharmacy and pharmacology.

[5]  R. Tissot,et al.  The decrease of erythrocyte catechol‐O‐methyltransferase activity in depressed patients and its diagnostic significance , 1987, Acta psychiatrica Scandinavica.

[6]  D. Stüber,et al.  System for High-Level Production in Escherichia coli and Rapid Purification of Recombinant Proteins: Application to Epitope Mapping, Preparation of Antibodies, and Structure—Function Analysis , 1990 .

[7]  A. Jalanko,et al.  Cloning and Characterization of Human Placental Catechol--Methyltransferase cDNA , 1991 .

[8]  P. Ball,et al.  Purification and properties of a catechol-o-methyltransferase of human liver. , 1971, European journal of biochemistry.

[9]  J. Axelrod Methylation reactions in the formation and metabolism of catecholamines and other biogenic amines. , 1966, Pharmacological reviews.

[10]  K. Tipton,et al.  Catechol-O-methyltransferase and its role in catecholamine metabolism. , 1990, Advances in neurology.

[11]  H. Okayama,et al.  High-efficiency transformation of mammalian cells by plasmid DNA. , 1987, Molecular and cellular biology.

[12]  Z Dembic,et al.  Human catechol-O-methyltransferase: cloning and expression of the membrane-associated form. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[13]  A. Rivett,et al.  Kinetic studies on the O-methylation of dopamine by human brain membrane-bound catechol O-methyltransferase. , 1982, Biochemistry.

[14]  R. Weinshilboum,et al.  Inheritance of low erythrocyte catechol-o-methyltransferase activity in man. , 1977, American journal of human genetics.

[15]  P. Mikulka,et al.  Deprivation Level, Competing Responses, and the Pre , 1966, Psychological reports.

[16]  M. da Prada,et al.  Ro 40-7592, a novel, very potent, and orally active inhibitor of catechol-O-methyltransferase: a pharmacological study in rats. , 1990, Advances in neurology.

[17]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[18]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[19]  N. Morton,et al.  Erythrocyte catechol-O-methyltransferase activity: genetic analysis in nuclear families with one child affected by Down syndrome. , 1985, American journal of medical genetics.

[20]  S. Gottesman,et al.  Role of sulA and sulB in filamentation by lon mutants of Escherichia coli K-12 , 1981, Journal of bacteriology.

[21]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Weinshilboum,et al.  Human erythrocyte phenol O-methyltransferase: radiochemical microassay and biochemical properties. , 1978, Clinica chimica acta; international journal of clinical chemistry.

[23]  N. Kalkkinen,et al.  Molecular cloning and characterization of rat liver catechol-O-methyltransferase. , 1990, Gene.

[24]  D. Burk,et al.  The Determination of Enzyme Dissociation Constants , 1934 .

[25]  A Francis,et al.  Distinct Cellular Localization of Membrane‐Bound and Soluble Forms of Catechol‐O‐Methyltransferase in Brain , 1983, Journal of neurochemistry.

[26]  Roth Ja,et al.  Kinetic studies on the O-methylation of dopamine by human brain membrane-bound catechol O-methyltransferase. , 1982 .

[27]  R. Borchardt,et al.  The purification and kinetic properties of liver microsomal-catechol-o-methyltransferase. , 1974, Life sciences.

[28]  M. Prada,et al.  Rapid and Sensitive Single‐Step Radiochemical Assay for Catechol‐O‐Methyltransferase , 1982, Journal of neurochemistry.

[29]  R. Weinshilboum,et al.  Human erythrocyte thiopurine methyltransferase: radiochemical microassay and biochemical properties. , 1978, Clinica chimica acta; international journal of clinical chemistry.

[30]  J. Roth Presence of membrane-bound catechol-O-methyltransferase in human brain. , 1980, Biochemical pharmacology.

[31]  J. Hoo,et al.  Catechol-O-methyltransferase of erythrocytes in patients with endogenous psychoses , 1981, Psychiatry Research.

[32]  X. Breakefield,et al.  Soluble and Particulate Forms of Rat Catechol‐O‐Methyltransferase Distinguished by Gel Electrophoresis and Immune Fixation , 1985, Journal of neurochemistry.

[33]  B. Bertocci,et al.  Immunoaffinity purification and partial amino acid sequence analysis of catechol-O-methyltransferase from pig liver. , 1991, Biochimica et biophysica acta.

[34]  S. Haskill,et al.  cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Wu,et al.  Properties of catechol O-methyltransferases from brain and liver of rat and human. , 1975, The Biochemical journal.

[36]  A. Rivett,et al.  Contribution of Sulfate Conjugation, Deamination, and O‐Methylation to Metabolism of Dopamine and Norepinephrine in Human Brain , 1982, Journal of neurochemistry.